Cargando…

Effect of Ivabradine on Cardiac Ventricular Arrhythmias: Friend or Foe?

Life-threatening ventricular arrhythmias, such as ventricular tachycardia and ventricular fibrillation remain an ongoing clinical problem and their prevention and treatment require optimization. Conventional antiarrhythmic drugs are associated with significant proarrhythmic effects that often outwei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oknińska, Marta, Paterek, Aleksandra, Zambrowska, Zuzanna, Mackiewicz, Urszula, Mączewski, Michał
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537674/ https://www.ncbi.nlm.nih.gov/pubmed/34682854 http://dx.doi.org/10.3390/jcm10204732

Ejemplares similares

Ivabradine is as effective as metoprolol in the prevention of ventricular arrhythmias in acute non-reperfused myocardial infarction in the rat
por: Marciszek, Mariusz, et al.
Publicado: (2020)

Right ventricular myocardial oxygen tension is reduced in monocrotaline-induced pulmonary hypertension in the rat and restored by myo-inositol trispyrophosphate
por: Oknińska, Marta, et al.
Publicado: (2021)

Right Ventricle Remodelling in Left-Sided Heart Failure in Rats: The Role of Calcium Signalling
por: Paterek, Aleksandra, et al.
Publicado: (2022)

Arginase Inhibition Mitigates Bortezomib-Exacerbated Cardiotoxicity in Multiple Myeloma
por: Paterek, Aleksandra, et al.
Publicado: (2023)

Treatment of hypoxia‐dependent cardiovascular diseases by myo‐inositol trispyrophosphate (ITPP)‐enhancement of oxygen delivery by red blood cells
por: Oknińska, Marta, et al.
Publicado: (2020)

Beneficial effects of intravenous iron therapy in a rat model of heart failure with preserved systemic iron status but depleted intracellular cardiac stores
por: Paterek, Aleksandra, et al.
Publicado: (2018)

Does nitric oxide mediate the effects of ivabradine in patients with heart failure?
por: Mączewski, Michał
Publicado: (2018)

Dynamic Signatures of the Epigenome: Friend or Foe?
por: Machnik, Marta, et al.
Publicado: (2020)

Association of ivabradin use with ventricular arrhythmias in heart failure patients
por: Pay, L, et al.
Publicado: (2023)

ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)

Microbiome—Friend or Foe of Pancreatic Cancer?
por: Daniluk, Jaroslaw, et al.
Publicado: (2021)

Regulation of N6-Methyladenosine after Myocardial Infarction
por: Vausort, Mélanie, et al.
Publicado: (2022)

Effect of ivabradine on ventricular arrhythmias in heart failure patients with reduced ejection fraction
por: Pay, Levent, et al.
Publicado: (2023)

Echocardiography and cardiac resynchronisation therapy, friends or foes?
por: van Everdingen, W.M., et al.
Publicado: (2015)

Role of Autophagy in Proteostasis: Friend and Foe in Cardiac Diseases
por: Li, Jin, et al.
Publicado: (2018)

Is left ventricular hypertrophy a friend or foe of patients with aortic stenosis?
por: Davies, Cecilia, et al.
Publicado: (2018)

Friend and Foe
Publicado: (1890)

HAART and the liver: friend or foe?
por: Pineda, JA, et al.
Publicado: (2010)

Noradrenaline and the kidney: friends or foes?
por: Bellomo, Rinaldo, et al.
Publicado: (2001)

Candida glabrata, Friend and Foe
por: Tam, Phyllix, et al.
Publicado: (2015)

Oxygen: viral friend or foe?
por: Gan, Esther Shuyi, et al.
Publicado: (2020)

Fibronectin in Cancer: Friend or Foe
por: Lin, Tsung-Cheng, et al.
Publicado: (2019)

Zinc in the Brain: Friend or Foe?
por: Choi, Seunghyuk, et al.
Publicado: (2020)

Iron in Porphyrias: Friend or Foe?
por: Buzzetti, Elena, et al.
Publicado: (2022)

Pyroptosis in Cancer: Friend or Foe?
por: Lu, Xiuxia, et al.
Publicado: (2021)

Oxygen for the Newborn: Friend or Foe?
por: Perrone, Serafina, et al.
Publicado: (2023)

Inflammation and Nutrition: Friend or Foe?
por: Stumpf, Franziska, et al.
Publicado: (2023)

Cow’s Milk Processing—Friend or Foe in Food Allergy?
por: Geiselhart, Sabine, et al.
Publicado: (2021)

Nucleolar stress: Friend or foe in cardiac function?
por: Yan, Daliang, et al.
Publicado: (2022)

Obesity: Friend or foe for osteoporosis
por: Sharma, Sudhaa, et al.
Publicado: (2014)

Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity
por: Ramji, Kavita, et al.
Publicado: (2022)

Alcohol: Its Friends and Foes
Publicado: (1874)

Type I interferon: friend or foe?
por: Trinchieri, Giorgio
Publicado: (2010)

STAT3 in Cancer—Friend or Foe?
por: Zhang, Hai-Feng, et al.
Publicado: (2014)

Beta-blockers: friend or foe in asthma?
por: Arboe, Bente, et al.
Publicado: (2013)

NFKB1 and Cancer: Friend or Foe?
por: Concetti, Julia, et al.
Publicado: (2018)

MDR1 in immunity: friend or foe?
por: Bossennec, Marion, et al.
Publicado: (2018)

EGFR Signaling: Friend or Foe for Cartilage?
por: Qin, Ling, et al.
Publicado: (2019)

Neuroinflammation: friend and foe for ischemic stroke
por: Jayaraj, Richard L., et al.
Publicado: (2019)

Ginseng for Liver Injury: Friend or Foe?
por: Kim, Tae-Woo
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p84sfi0a1547k54fhv82hugrpo